• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医生主导的1型脊髓性肌萎缩症患儿护理差异。

Physician driven variation in the care of children with spinal muscular atrophy type 1.

作者信息

Oskoui Maryam, Ng Pamela, Liben Stephen, Zielinski David

机构信息

Department of Pediatrics, McGill University, Montréal, QC, Canada.

Department of Neurology and Neurosurgery, McGill University, Montréal, QC, Canada.

出版信息

Pediatr Pulmonol. 2017 May;52(5):662-668. doi: 10.1002/ppul.23616. Epub 2016 Sep 29.

DOI:10.1002/ppul.23616
PMID:27685758
Abstract

BACKGROUND

Increasing numbers of families are requesting active supportive management for their child with spinal muscular atrophy type 1 (SMA1), leading to longer survival and greater prevalence of affected children. Strong opinions exist among physicians for and against the provision of care measures prolonging life.

OBJECTIVE

To describe current practice in the care of SMA1 in Canada, and explore the factors underlying inter-physician variability.

METHODS

A cross-sectional survey of Canadian hospital-based pediatric neurologists and pediatric respirologists was performed in 2015. Odds ratios and 95% confidence intervals were calculated to compare proportions between groups.

RESULTS

There was a 54% completion rate (99 physicians). Over half of participants believed that a disease modifying therapy was likely within 10 years. Quebec respirologists were 50 times less likely to offer long-term non-invasive ventilation (NIV) than respirologists in other provinces (OR 50.6, 95% CI 2.4-1075.3), and 20 times less likely to discuss tracheostomy with families (OR 20.4, 95% CI 2.0-211.8). High raters of perceived happiness of affected children were more likely to find NIV an acceptable measure for acute (OR 6.7, 95% CI 1.7-26.0) and chronic (OR 13.7, 95% CI 4.0-46.4) respiratory failure and prophylactic use (OR 5.8, 95% CI 2.2-15.6).

CONCLUSION

Physician knowledge, opinions, subjective perception of child happiness, and regional factors, all influence physicians' practices and the shared decision-making process. Parents may not be informed or offered all the services available to their child. Knowledge translation initiatives are needed to enhance SMA1 care. Pediatr Pulmonol. 2017;52:662-668. © 2016 Wiley Periodicals, Inc.

摘要

背景

越来越多的家庭要求对患有1型脊髓性肌萎缩症(SMA1)的孩子进行积极的支持性管理,这使得患病儿童的存活时间延长,患病率增加。医生对于是否提供延长生命的护理措施存在强烈的不同意见。

目的

描述加拿大目前对SMA1的护理实践,并探讨医生之间存在差异的潜在因素。

方法

2015年对加拿大以医院为基础的儿科神经科医生和儿科呼吸科医生进行了一项横断面调查。计算比值比和95%置信区间以比较组间比例。

结果

完成率为54%(99名医生)。超过半数的参与者认为在10年内可能会有疾病改善疗法。魁北克省的呼吸科医生提供长期无创通气(NIV)的可能性比其他省份的呼吸科医生低50倍(比值比50.6,95%置信区间2.4 - 1075.3),与家庭讨论气管切开术的可能性低20倍(比值比20.4,95%置信区间2.0 - 211.8)。认为患病儿童幸福感高的评分者更有可能认为NIV是急性(比值比6.7,95%置信区间1.7 - 26.0)和慢性(比值比13.7,95%置信区间4.0 - 46.4)呼吸衰竭以及预防性使用(比值比5.8,95%置信区间2.2 - 15.6)的可接受措施。

结论

医生的知识、意见、对儿童幸福感的主观认知以及地区因素,都会影响医生的实践和共同决策过程。家长可能未被告知或未获得其孩子可享有的所有服务。需要开展知识转化倡议以改善SMA1的护理。《儿科肺病学》。2017年;52:662 - 668。© 2016威利期刊公司

相似文献

1
Physician driven variation in the care of children with spinal muscular atrophy type 1.医生主导的1型脊髓性肌萎缩症患儿护理差异。
Pediatr Pulmonol. 2017 May;52(5):662-668. doi: 10.1002/ppul.23616. Epub 2016 Sep 29.
2
Respiratory support in spinal muscular atrophy type I: a survey of physician practices and attitudes.I型脊髓性肌萎缩症的呼吸支持:医生实践与态度调查
Pediatrics. 2002 Aug;110(2 Pt 1):e24. doi: 10.1542/peds.110.2.e24.
3
Physician attitudes towards ventilatory support for spinal muscular atrophy type 1 in Australasia.澳大利亚和新西兰医生对1型脊髓性肌萎缩症通气支持的态度。
J Paediatr Child Health. 2007 Dec;43(12):790-4. doi: 10.1111/j.1440-1754.2007.01197.x. Epub 2007 Sep 4.
4
Spinal muscular atrophy type 1: management and outcomes.1型脊髓性肌萎缩症:管理与结局
Pediatr Pulmonol. 2002 Jul;34(1):16-22. doi: 10.1002/ppul.10110.
5
POINT: Is Noninvasive Ventilation Always the Most Appropriate Manner of Long-term Ventilation for Infants With Spinal Muscular Atrophy Type 1? Yes, Almost Always.观点:对于1型脊髓性肌萎缩症婴儿,无创通气始终是长期通气的最合适方式吗?是的,几乎总是如此。
Chest. 2017 May;151(5):962-965. doi: 10.1016/j.chest.2016.11.043. Epub 2016 Dec 15.
6
International survey of physician recommendation for tracheostomy for Spinal Muscular Atrophy Type I.国际调查:医师对脊髓性肌萎缩症Ⅰ型行气管切开术的推荐情况。
Pediatr Pulmonol. 2012 Jun;47(6):606-11. doi: 10.1002/ppul.21617. Epub 2011 Dec 13.
7
Noninvasive airway approaches for acute neuromuscular respiratory failure in emergency departments.急诊科急性神经肌肉呼吸衰竭的无创气道处理方法
Pediatr Pulmonol. 2017 Oct;52(10):E55-E57. doi: 10.1002/ppul.23693.
8
Spinal muscular atrophy type 1: A noninvasive respiratory management approach.1型脊髓性肌萎缩症:一种无创呼吸管理方法。
Chest. 2000 Apr;117(4):1100-5. doi: 10.1378/chest.117.4.1100.
9
The role of sleep diagnostics and non-invasive ventilation in children with spinal muscular atrophy.睡眠诊断和无创通气在脊髓性肌萎缩症患儿中的作用。
Paediatr Respir Rev. 2018 Sep;28:18-25. doi: 10.1016/j.prrv.2018.07.006. Epub 2018 Jul 24.
10
Spinal muscular atrophy type 1: avoidance of hospitalization by respiratory muscle support.脊髓性肌萎缩症 1 型:通过呼吸肌支持避免住院治疗。
Am J Phys Med Rehabil. 2011 Nov;90(11):895-900. doi: 10.1097/PHM.0b013e318232883a.

引用本文的文献

1
Changes in Ventilatory Support Requirements of Spinal Muscular Atrophy (SMA) Patients Post Gene-Based Therapies.基于基因疗法后脊髓性肌萎缩症(SMA)患者通气支持需求的变化
Children (Basel). 2022 Aug 11;9(8):1207. doi: 10.3390/children9081207.
2
Evaluation of a Case Management to Support Families With Children Diagnosed With Spinal Muscular Atrophy-Protocol of a Controlled Mixed-Methods Study.一项支持脊髓性肌萎缩症患儿家庭的病例管理评估——一项对照混合方法研究的方案
Front Pediatr. 2021 Aug 3;9:614512. doi: 10.3389/fped.2021.614512. eCollection 2021.
3
Burden of Spinal Muscular Atrophy (SMA) on Patients and Caregivers in Canada.
加拿大脊髓性肌萎缩症(SMA)患者和照护者的负担。
J Neuromuscul Dis. 2021;8(4):553-568. doi: 10.3233/JND-200610.
4
Parents' perspectives on nusinersen treatment for children with spinal muscular atrophy.家长对脊髓性肌萎缩症患儿使用nusinersen 治疗的看法。
Dev Med Child Neurol. 2021 Jul;63(7):816-823. doi: 10.1111/dmcn.14825. Epub 2021 Feb 6.
5
Decisions for Long-Term Ventilation for Children. Perspectives of Family Members.儿童长期通气决策。家庭成员的观点。
Ann Am Thorac Soc. 2020 Jan;17(1):72-80. doi: 10.1513/AnnalsATS.201903-271OC.
6
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials.七项临床试验中接受 nusinersen 治疗的有症状脊髓性肌萎缩症(SMA)婴儿和儿童的综合安全性分析。
CNS Drugs. 2019 Sep;33(9):919-932. doi: 10.1007/s40263-019-00656-w.
7
Effect of new modalities of treatment on physicians management plan for patients with spinal muscular atrophy.新治疗方式对脊髓性肌萎缩症患者医生管理计划的影响
Neurosciences (Riyadh). 2019 Jan;24(1):16-21. doi: 10.17712/nsj.2019.1.20180321.
8
Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives.脊髓性肌萎缩症的经济、机会和心理社会成本:对澳大利亚照顾者观点的探索性定性分析。
BMJ Open. 2018 May 24;8(5):e020907. doi: 10.1136/bmjopen-2017-020907.
9
Indirect estimation of the prevalence of spinal muscular atrophy Type I, II, and III in the United States.美国 I、II 和 III 型脊髓性肌萎缩症患病率的间接估计。
Orphanet J Rare Dis. 2017 Nov 28;12(1):175. doi: 10.1186/s13023-017-0724-z.
10
Decisions around Long-term Ventilation for Children. Perspectives of Directors of Pediatric Home Ventilation Programs.儿童长期通气决策。儿科家庭通气项目主任的观点。
Ann Am Thorac Soc. 2017 Oct;14(10):1539-1547. doi: 10.1513/AnnalsATS.201612-1002OC.